Global Embolic Protection Devices Market Trends and Industry Analysis Report 2020
North America dominated the global Embolic Protection Devices Market.
(firmenpresse) - Factors such as the rising incidence of cardiovascular and neurovascular diseases, growing funding and investments, the launch of technologically advanced embolic protection devices, and rising demand for minimally invasive procedures are expected to drive the growth of the market. On the other hand, product failures and recalls may hinder the overall market growth to a certain extent during the forecast period.
What the Market Looks Like?
Predicted to grow at a CAGR of 8.3% during the forecast period, the global Embolic Protection Devices Market is estimated to reach USD 604.9 Million by the end of 2023.
Based on application, the embolic protection devices market is segmented into cardiovascular, neurovascular, and peripheral vascular diseases. According to this study, the neurovascular diseases segment is poised to grow at the fastest growth rate in the market. With the increasing target patient population, the demand for embolic protection devices for the treatment of neurovascular diseases is expected to increase during the forecast period.
Based on the indications, the embolic protection devices segment is further segmented into percutaneous coronary intervention, transcatheter aortic valve replacement (TAVR), carotid artery diseases, saphenous vein graft disease, and other indications. The percutaneous coronary intervention segment accounted for the largest share of the global market. The large share of this segment can primarily be attributed to the increasing prevalence of CAD and the rising preference for minimally invasive procedures.
Among end users, hospitals are the fastest growing end-user segment in the market during the forecast period. The market for this segment is mainly driven by factors such as the growing number of angioplasty procedures in hospitals, rising incidence of chronic vascular diseases, favorable reimbursement scenario in developed countries, increasing number of hospitals, and increasing government initiatives to provide quality treatment for cardiovascular diseases.
Download PDF Brochure (at) https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=158143803
What Drives the Market?
The growth of the global market for Embolic Protection Devices is primarily influenced by the following factors:
& Neurovascular Diseases
&D on Embolic Protection Devices
Geographical growth scenario of Embolic Protection Devices Market
Geographically, the market is segmented into North America, Europe, Asia Pacific, Latin America and the Middle East and Africa. The rising geriatric population, prevalence of cardiovascular and neurovascular diseases, increasing adoption of minimally invasive techniques, increasing availability of funding, and presence of a large number of medical device product manufacturers are driving the growth of the market in North America.
on the other hand, Asia Pacific is expected to grow at the highest CAGR during the forecast period due to the growing number of prescriptions for people aged 65 or above, increasing healthcare spending, rising healthcare costs, and increasing target population.
Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=158143803
Leading market players and strategies adopted
The prominent players in the Embolic Protection Devices Market include Boston Scientific (US), Medtronic Ireland), Abbott (US), Cordis (A Cardinal Health Company) (US), Allium Medical Solutions (Israel), Contego Medical (US), W.L. Gore & Associates (US), Silk Road Medical (US), Claret Medical (US), and AngioSlide (Israel).
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales(at)marketsandmarkets.com
Datum: 11.02.2020 - 01:02 Uhr
Sprache: Deutsch
News-ID 1555854
Anzahl Zeichen: 2339
contact information:
Contact person: shelly singh
Town:
northbook
Phone: 18886006441
Kategorie:
Research & Development
Typ of Press Release: Financial
type of sending: send
Date of sending: 11.02.2020
Anmerkungen:
Diese Pressemitteilung wurde bisher 418 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Global Embolic Protection Devices Market Trends and Industry Analysis Report 2020
"
steht unter der journalistisch-redaktionellen Verantwortung von
marketsandmarkets (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
